ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Nabla Bio
Nabla Bio is leveraging advanced AI to revolutionize therapeutic design and develop new drug formats, focusing on challenging diseases and fast drug development. The company combines cutting-edge machine learning with laboratory validation, aiming to push the boundaries of medicine discovery.
Nabla is a biotech company that uses machine learning and generative models to design drug‑like antibodies and protein therapeutics. Its platform (including the JAM‑2 model) produces candidate antibody sequences “straight from the computer” to accelerate discovery and reduce experimental cycles. Nabla partners with pharma and biotech to integrate computational design into discovery pipelines, combining sequence/structure modeling and developability considerations. The company publishes technical reports and offers platform access and collaboration to move in‑silico candidates toward developable biologics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nabla Bio.